Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 3Hepatitis C, Chronic 2Hepatitis C 2Recurrence 1Lymphoma, Non-Hodgkin 1Liver Neoplasms 1Liver Diseases 1Hepatitis 1Bronchiolitis Obliterans Syndrome 1

Interventions

Mycophenolic Acid 2Blood Specimen Collection 2vedolizumab 1bavituximab 1Ursodeoxycholic Acid 1Surveys and Questionnaires 1Steroids 1Spermine Synthase 1Sorafenib 1Sofosbuvir 1Ribavirin 1Prednisone 1Photopheresis 1Phlebotomy 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Methoxsalen 1Liquid Biopsy 1Infliximab 1Clinical Protocols 1Azathioprine 1Adrenal Cortex Hormones 13-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hepatitis × Sofosbuvir × Clear all
NCT01559844 2016-07-27

Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant

Gilead Sciences

Phase 2 Completed
61 enrolled 25 charts
Gastrointestinal

Bronchiolitis Obliterans Syndrome, Hepatitis, Hepatitis C, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡